This expanded access study is designed to provide RAD001 to patients with MRCC who are without satisfactory treatment alternatives, until RAD001 becomes commercially available.
Study Type
EXPANDED_ACCESS
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Highlands oncology Group, PA
Springdale, Arkansas, United States
University of Colorado Health Sciences Center/Anschutz Pavillion
Aurora, Colorado, United States
Cancer Centers of Florida, P.A.
Ocoee, Florida, United States
MD Anderson Cancer Center - Orlando
Orlando, Florida, United States
Indiana University Cancer center
Indianapolis, Indiana, United States
The Cancer Institute, St. Joseph Medical Center
Towson, Maryland, United States
Henry Ford Health System
Detroit, Michigan, United States
Missouri Cancer Associates
Columbia, Missouri, United States
Heartland Hematology-Oncology Associates, Inc.
Kansas City, Missouri, United States
Washington University/Siteman Cancer Center
St Louis, Missouri, United States
...and 74 more locations